New neuroscience research identifies Glutamine Synthetase as the key enzyme driving postnatal brain maturation and neuronal ...

March 23, 2026 Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with ...

The human brain develops through an intricate balance of cellular growth, connectivity, and metabolism. A new study reveals ...

The name might sound like a Nordic god, but it is actually the molecular machinery that allows many different species to eat ...

Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the QTORIN™ platform, in development for serious, rare skin diseases and ...

Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.

Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...

DURHAM, N.C., March 17, 2026 - MedPharm, a global leader in topical and transdermal contract drug development and ...

L-leucine, an FDA-approved compound, exerts neuroprotective effects in Parkinson’s disease models. By reducing ...

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth ...

News, features, and commentary about cancer-related issues ...